Destiny Tech100 (DXYZ) shares surged 7.47% following reports that SpaceX has confidentially filed for an IPO with the SEC, potentially valuing the company at over $1.75 trillion. The closed-end fund holds stakes in high-growth tech companies including SpaceX, OpenAI, Stripe, Epic Games, and Discord. Technical indicators show neutral momentum with bullish MACD signals.

The global ETF market has surpassed $19 trillion in assets with 96% of institutional investors planning to increase ETF exposure over the next 12 months. Active ETFs are driving growth with two-thirds of investors favoring active over passive strategies. Private market ETFs represent an emerging opportunity, though structural challenges around liquidity and pricing remain. Financial literacy is identified as the biggest barrier to broader ETF adoption.

ETF managers are increasingly offering exposure to private companies like SpaceX through public funds, with Baron First Principles ETF allocating ~14% to the aerospace company. While this provides early access to potential IPO gains, structural challenges around liquidity and valuation transparency remain concerns. The trend signals a blurring line between public and private investing.

SpaceX is expected to go public in June 2026, potentially timed to coincide with a rare Jupiter-Venus planetary alignment on June 8-9 and Elon Musk's birthday on June 28. The $50 billion IPO could push Musk's net worth to trillionaire status if SpaceX is valued at $1.5 trillion. Investors can currently gain exposure through companies holding SpaceX stakes or space-focused ETFs.

The article compares two closed-end funds (CEFs): Destiny Tech100 (DXYZ), a risky investment with high premium and speculative holdings, and BlackRock Technology and Private Equity Term Trust (BTX), a more stable fund with a 9.9% monthly dividend yield.

The article warns investors to sell three overpriced and overhyped closed-end funds (CEFs) that are due for a fall due to rising inflation, interest rates, and economic slowdown.

Elon Musk's Starlink has refused to comply with a Brazilian court order to block the social media platform X, defying the government's decision to ban the platform due to the spread of hate messages and misinformation.

Editor’s note: This story has been updated with additional details. Multiple stocks on the New York Stock Exchange experienced sudden trading halts after 9:40 a.m. ET Monday due to technical issues. The unexpected pauses in trading were triggered by a technical issue categorized under the “Limit Up/Limit Down” code, which is typically used to curb excessive volatility in a single stock. The NYSE said it is investigating the reported technical issue. “Additional information will follow as soon as possible,” NYSE-owner Intercontinental Exchange Inc. (NYSE:ICE) stated. Among the largest companies halted on Monday were Berkshire Hathaway Inc. (NYSE:BRK) at 9:50:52 a.m. ET and Chipotle Mexican Grill, Inc. (NYSE:CMG) at 9:44:58 a.m. ET. Chipotle shares experienced a sudden and dramatic decline of 66%, plummeting ...Full story available on Benzinga.com

While the stock market has demonstrated some resiliency in the face of lingering inflation, investors have other opportunities too.

Investing in start-ups has wide appeal, and this fund allows you to mimic the moves of high-profile billionaires.

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier. Travelers shares dipped 8.1% to $205.03 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024. Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results. Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350. VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday. AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70. The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider. EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market. CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461. WiSA Technologies, Inc. (NASDAQ:

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro. INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold. Chromocell Therapeutics Corporation (NYSE: CHRO) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday. Clene Inc. (NASDAQ: CLNN) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting. VIA optronics AG (NYSE: VIAO) shares ...